THE COST-EFFECTIVENESS AND COST-UTILITY OF PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA IN GUATEMALA

被引：1
|
作者：
Obando, C. A. [1 ]
Gonzalez, L. [2 ]
Muschett, D. [1 ]
机构：
[1] Janssen, Panama City, Panama
[2] Janssen, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2089
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A695 / A695
页数：1
相关论文
共 50 条
  • [21] A cost-utility and cost-effectiveness analysis of an acute pain service
    Stadler, M
    Schlander, M
    Braeckman, M
    Nguyen, T
    Boogaerts, JG
    JOURNAL OF CLINICAL ANESTHESIA, 2004, 16 (03) : 159 - 167
  • [22] Reviewing the literature of cost-effectiveness and cost-utility analysis in health
    Sancho, Leyla Gomes
    CADERNOS DE SAUDE PUBLICA, 2008, 24 (12): : 2735 - 2746
  • [23] Cost-effectiveness and cost-utility analyses of three different gargles in the treatment of chronic periodontitis
    Chen, Xin
    Niu, Wenzhi
    Hu, Guangyu
    Chen, Changfeng
    PLOS ONE, 2024, 19 (05):
  • [24] Cost-benefit, cost-effectiveness and cost-utility analyses of periodontitis prevention
    Braegger, U
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2005, 32 : 301 - 313
  • [25] Cost-effectiveness analysis of paliperidone palmitate versus long-acting risperidone as maintenance treatment in schizophrenia patients in Italy
    Ravasio, Roberto
    Nicole, Giuseppe
    Vaggi, Marco
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2015, 2 (01) : 17 - 32
  • [26] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE 3-MONTH VERSUS 1-MONTH FOR THE TREATMENT OF SCHIZOPHRENIA IN THE UNITED STATES
    Asgharian, A.
    Khushalani, A. S.
    Kremenova, L.
    Karki, S.
    Khan, S.
    Akat, M.
    Magruder, A.
    Blanchette, C. M.
    VALUE IN HEALTH, 2019, 22 : S227 - S227
  • [27] Cost Effectiveness of Paliperidone Palmitate for the Treatment of Schizophrenia in Germany (vol 11, pg 509, 2013)
    Zeidler, Jan
    Mahlich, Joerg
    Greiner, Wolfgang
    Heres, Stephan
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2013, 11 (06) : 689 - 689
  • [28] Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain
    Einarson, Thomas R.
    Bereza, Basil G.
    Llinares, Ignacio Garcia
    Moro, Beatriz Gonzalez Martin
    Tedouri, Fadi
    Van Impe, Kristel
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1039 - 1047
  • [29] Cost-effectiveness in the treatment of schizophrenia
    Knapp, MRJ
    EUROPEAN PSYCHIATRY, 1996, 11 (03) : 137 - 143
  • [30] Analysis of cost-effectiveness and cost-utility for immunosuppressive protocols in renal transplantation
    Keown, P
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1140 - 1141
12345